✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Kobo Biotech Ltd.

KOBO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹8 Cr.
P/E
0.00

Kobo Biotech Ltd.

  • Kobo Biotech
  • Senbo Industries
  • Hind Bio Science

FAQs on Kobo Biotech Ltd. Shareprice

Kobo Biotech has given lower returns compared to its competitors.
Kobo Biotech has grown at ~-11.97% over the last 9yrs while peers have grown at a median rate of 5.1%

There is insufficient historical data to gauge this.
Latest PE of Kobo Biotech is 0

View FAQ's On Business

Growth Table

  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Balance Sheet

  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Cash Flow

  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Quarterly Results

  • Kobo Biotech Ltd.
  • Senbo Industries
  • Hind Bio Science

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Kobo Biotech Ltd. Financials

Kobo Biotech balance sheet is weak and might have solvency issues

Yes, The net debt of Kobo Biotech is increasing.
Latest net debt of Kobo Biotech is ₹140 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹140 Crs.

Yes, profit is increasing.
The profit of Kobo Biotech is -₹5.46 Crs for TTM, -₹5.55 Crs for Mar 2023 and -₹15.23 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kobo Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech